Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

• 用替米沙坦、雷米普利或二者联合治疗高血管风险人群对肾脏功能指标的影响(ONTARGET研究)：一项多中心、随机、双盲、对照试验。